← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Arsenal Medical, Inc.
Waltham, MA
$4,342,171
Total funding
4
Grants
Funding over time
peak $1.1M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,342,171 · 4
By mechanism
R44$3,660,607 · 2
R43$681,564 · 2
Investigators at Arsenal Medical, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Flow Responsive Embolic Agent for the Complete Devascularization of Meningiomas$1,117,374
R44 · FY2022 · CA
Flow Responsive Embolic Agent for the Complete Devascularization of Meningiomas$791,378
R44 · FY2021 · CA
Development of Self-Expanding Foams for Percutaneous Damage Control of Retroperitoneal Pelvic Exsanguination$762,094
R44 · FY2017 · GM
Development of Self-Expanding Foams for Percutaneous Damage Control of Retroperitoneal Pelvic Exsanguination$762,094
R44 · FY2018 · GM
Ideal Embolic for Portal Vein Embolization$367,201
R43 · FY2020 · HL
Engineering a Middle Meningeal Artery Embolization Model with Hydrophilicity and Hydraulic Resistance$314,363
R43 · FY2025 · NS
Development of Self-Expanding Foams for Percutaneous Damage Control of Retroperitoneal Pelvic Exsanguination$227,667
R44 · FY2016 · GM